We are delighted to announce that Dr Phoebe McCrorie (pictured above), a Post-Doctoral Research Fellow at the University of Nottingham, has been awarded the prestigious British Neuro-Oncology Society (BNOS) Young Investigator of the Year Award for 2025. This award, co-sponsored by Brain Tumour Research, recognises young researchers who have made outstanding contributions to neuro-oncology in the UK.
Dr McCrorie has dedicated her career to neuro-oncology, with a focus on the discovery and delivery of new and repurposed drugs directly into tumours. After completing her PhD at the University of Nottingham, where she developed a local drug delivery system for glioblastoma, Dr McCrorie investigated druggable targets against group 3 medulloblastoma and atypical teratoid/rhabdoid tumours (ATRT) with funding from The Little Princess Trust. Currently, her project, funded by the Medical Research Council, aims to understand how glioblastoma drugs penetrate brain tissue using advanced mass spectrometry techniques.
Expressing her gratitude, Dr McCrorie said, “I am extremely grateful and proud to be chosen as the 2025 BNOS Young Investigator of the Year. The previous Young Investigators have carried out incredible research and have gone on to successful careers in neuro-oncology, which is something I aspire to do. I feel very lucky to be recognised for the work I have carried out so far and what I plan to do in the future."
Brain Tumour Research is proud to co-sponsor this award, highlighting our commitment to supporting Early Career Researchers and growing capacity within neuro-oncology research. As part of this honour, Dr McCrorie spoke at the BNOS Annual Conference in London this week and will receive £2,000 to attend other neuro-oncology conferences.
Congratulations to Dr Phoebe McCrorie on this well-deserved recognition. We eagerly anticipate the impact of her research on the future of neuro-oncology.
Related reading:
